Liraglutide therapy in Prader-Willi syndrome

Diabetic Medicine

Volumn 28, Issue 6, 2011, Pages 755-756

  Cyganek, K ^a   Koblik, T ^a   Kozek, E ^a,b   Wojcik, M ^c   Starzyk, J ^c   Malecki, M T ^a,b  

^a UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; C PEPTIDE; EXENDIN 4; GHRELIN; GLICLAZIDE; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; LIRAGLUTIDE; METFORMIN;

ADIPOSE TISSUE; BLOOD GLUCOSE MONITORING; CASE REPORT; CHOLECYSTECTOMY; CHOLELITHIASIS; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DNA METHYLATION; FACE DYSMORPHIA; FEMALE; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONAL THERAPY; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN TREATMENT; LETTER; MORBID OBESITY; MUSCLE HYPOTONIA; MYOPIA; PATIENT REFERRAL; PRADER WILLI SYNDROME; SCHEUERMANN DISEASE; SHORT COURSE THERAPY; SLEEP APNEA SYNDROME; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; METFORMIN; OBESITY, MORBID; PRADER-WILLI SYNDROME; TREATMENT OUTCOME;

EID: 79955960964     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03280.x     Document Type: Letter

References (5)

1. Lovshin JA, Drucker DJ. Incretin-based therapies for type2 diabetes mellitus. Nat Rev Endocrinol 2009; 5: 262-269.
2. Astrup A, Rössner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009; 374: 1606-1616.
3. Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 2670-2678.
4. Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. Recommendations for the diagnosis and management of Prader-Willi syndrome; speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS. J Clin Endocrinol Metab 2008; 93: 4183-4197.
5. Pérez-Tilve D, González-Matías L, Alvarez-Crespo M, Leiras R, Tovar S, Diéguez C et al. Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes 2007; 56: 143-151.